CSL Ownership
CMXHF Stock | USD 173.50 0.90 0.52% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
CSL |
CSL Pink Sheet Ownership Analysis
About 36.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 6th of September 2022. CSL Limited had 3:1 split on the 19th of October 2007. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.The quote for CSL Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CSL Limited please contact Paul BA at 61 3 9389 1911 or go to https://www.csl.com.au.Currently Active Assets on Macroaxis
Other Information on Investing in CSL Pink Sheet
CSL financial ratios help investors to determine whether CSL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.